...
首页> 外文期刊>JAIDS: Journal of acquired immune deficiency syndromes >Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care
【24h】

Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care

机译:缩小可获得护理的艾滋病毒感染者和未感染艾滋病毒的人之间的预期寿命差距

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background:It is unknown if a survival gap remains between HIV-infected and HIV-uninfected individuals with access to care.Methods:We conducted a cohort study within Kaiser Permanente California during 1996-2011, using abridged life tables to estimate the expected years of life remaining (life expectancy) at age 20.Results:Among 24,768 HIV-infected and 257,600 HIV-uninfected individuals, there were 2229 and 4970 deaths, with mortality rates of 1827 and 326 per 100,000 person-years, respectively. In 1996-1997, life expectancies at age 20 for HIV-infected and HIV-uninfected individuals were 19.1 and 63.4 years, respectively, corresponding with a gap of 44.3 years (95% confidence interval: 38.4 to 50.2). Life expectancy at age 20 for HIV-infected individuals increased to 47.1 years in 2008 and 53.1 years by 2011, narrowing the gap to 11.8 years (8.9-14.8 years) in 2011. In 2008-2011, life expectancies at age 20 for HIV-infected individuals ranged from a low of 45.8 years for blacks and 46.0 years for those with a history of injection drug use to a high of 52.2 years for Hispanics. HIV-infected individuals who initiated antiretroviral therapy with CD4 500 cells per microliter had a life expectancy at age 20 of 54.5 years in 2008-2011, narrowing the gap relative to HIV-uninfected individuals to 7.9 years (5.1-10.6 years). For these HIV-infected individuals, the gap narrowed further in subgroups with no history of hepatitis B or C infection, smoking, drug/alcohol abuse, or any of these risk factors.Conclusions:Even with early treatment and access to care, an 8-year gap in life expectancy remains for HIV-infected compared with HIV-uninfected individuals.
机译:背景:尚不清楚HIV感染者和未感染HIV的个体之间仍然存在生存差距。方法:我们在1996年至2011年间于加利福尼亚州凯撒永久医院进行了一项队列研究,使用删减的生命表来估计预期寿命。 20岁时的剩余寿命(预期寿命)结果:在24,768例HIV感染者和257,600例HIV未感染者中,分别有2229和4970例死亡,死亡率分别为每10万人年1827和326。在1996-1997年间,HIV感染者和未感染HIV者在20岁时的预期寿命分别为19.1岁和63.4岁,差距为44.3岁(95%置信区间:38.4至50.2)。 HIV感染者的20岁预期寿命在2008年增加到47.1岁,到2011年增加到53.1岁,并将这一差距在2011年缩小到11.8岁(8.9-14.8岁)。在2008-2011年,HIV-感染者20岁的预期寿命-感染者的范围从黑人低至45.8岁,注射吸毒史的46.0岁到西班牙裔高至52.2年不等。最初以每微升CD4 500细胞进行抗逆转录病毒治疗的HIV感染者在2008年至2011年的20岁时的预期寿命为54.5岁,相对于未感染HIV的个体而言,这一差距缩小到7.9年(5.1-10.6岁)。对于这些感染了HIV的个体,在没有乙型或丙型肝炎感染,吸烟,药物/酒精滥用或任何这些危险因素的病史的亚组中,差距进一步缩小。结论:即使有早期治疗和就医机会,8与未感染艾滋病毒的人相比,艾滋病毒感染者的预期寿命仍存在两年的差距。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号